About
Portable, smartphone-attached fundus cameras plus AI (Medios) for DR, glaucoma and AMD screening in low-resource settings. CDSCO approvals for DR AI (Oct 2024) and glaucoma/AMD modules (May 2025).
HQ: Bengaluru, India
Funding
~$25M total over 10 rounds; most recent major round led by Sun Pharma (Feb 2023)
A claimed 2024 $25M raise at $67.5M valuation conflicts with Tracxn cumulative figures.